Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis.

× No keyword cloud information.

58 in total

1. Decreased microglial activation in MS patients treated with glatiramer acetate.

Authors: John N Ratchford; Christopher J Endres; Dima A Hammoud; Martin G Pomper; Navid Shiee; John McGready; Dzung L Pham; Peter A Calabresi
Journal: J Neurol Date: 2011-12-09 Impact factor: 4.849

2. Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions.

Authors: L A Boven; L Montagne; H S Nottet; C J De Groot
Journal: Clin Exp Immunol Date: 2000-11 Impact factor: 4.330

3. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells.

Authors: L Claudio; Y Kress; J Factor; C F Brosnan
Journal: Am J Pathol Date: 1990-11 Impact factor: 4.307

4. Pathophysiologic effect of interleukin-1b in the rabbit retina.

Authors: J A Martiney; M Litwak; J W Berman; J C Arezzo; C F Brosnan
Journal: Am J Pathol Date: 1990-12 Impact factor: 4.307

5. Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.

Authors: William J Karpus; Nathaneal Reynolds; Heather A Behanna; Linda J Van Eldik; D Martin Watterson
Journal: J Neuroimmunol Date: 2008-10-15 Impact factor: 3.478

6. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement.

Authors: S J Piddlesden; H Lassmann; F Zimprich; B P Morgan; C Linington
Journal: Am J Pathol Date: 1993-08 Impact factor: 4.307

The effects of macrophage depletion on the clinical and pathologic expression of experimental allergic encephalomyelitis.

1. Decreased microglial activation in MS patients treated with glatiramer acetate.

2. Macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, and RANTES mRNA semiquantification and protein expression in active demyelinating multiple sclerosis (MS) lesions.

3. Mechanisms of edema formation in experimental autoimmune encephalomyelitis. The contribution of inflammatory cells.

4. Pathophysiologic effect of interleukin-1b in the rabbit retina.

5. Inhibition of experimental autoimmune encephalomyelitis by a novel small molecular weight proinflammatory cytokine suppressing drug.

6. The demyelinating potential of antibodies to myelin oligodendrocyte glycoprotein is related to their ability to fix complement.

Review 7. The role of macrophage subpopulations in autoimmune disease of the central nervous system.

8. Infiltrating monocytes trigger EAE progression, but do not contribute to the resident microglia pool.

Review 9. Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology.

Review 10. Phagocytosis of myelin in demyelinative disease: a review.